EMAT NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Evolution Metals & Technologies Corp. Common Stock · Basic Materials · Other Industrial Metals & Mining

Open interactive chart View report data
Latest close 2.81 USD
-23.2% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -62.2% below the Trend Line and sits at 1.2% of its 52-week range. The latest completed week returned -23.2%, after a -50.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.

Setup score 25 out of 100
Latest Close 2.81 USD 7 Aug 2026
1W Return -23.2% latest completed week
4W Return -50.1% short-term follow-through
12W Return -64.2% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 2.9x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -23.2% Latest completed week; four-week move -50.1%. Indicator stack 15/19 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 40 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -62.2% below the Trend Line and sits at 1.2% of its 52-week range. The latest completed week returned -23.2%, after a -50.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0112-week average 0.04

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -50.1% over four weeks, -64.2% over 12 weeks, and -74.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-23.2%
4W-50.1%
12W-64.2%
26W-54.2%
52W-74.5%
Active trend streak0 weeks
Active weeks in one year14
Trend breadth26.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.09Latest activity-pressure read.
Pressure change-142.7%Four-week change in activity pressure.
Leadership-74.06Latest relative-leadership reading.
RS change-43.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 55% Model confidence 51%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength64/100Blend of value, momentum, and quality. Underlying universe rank 37; rank 1 is best.
Value57/100Relative valuation strength. Underlying universe rank 44; rank 1 is best.
Quality54/100Profitability and accounting quality. Underlying universe rank 47; rank 1 is best.
Momentum56/100Medium-term price momentum. Underlying universe rank 45; rank 1 is best.
Growth57/100Revenue and earnings growth. Underlying universe rank 44; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
0.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 40 relevant articles.

3 positive · 35 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-88.3%Distance below the 52-week high.
13-week volatility10.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+61.5%Week of 13 Feb.
Worst week-27.8%Week of 31 Jul.
Latest week-23.2%Week of 7 Aug.

Shape of recent returns

Strong gains8
Modest gains4
Flat weeks0
Modest losses2
Sharp losses12
Recent vol10.5%13-week weekly-return volatility.
Base vol17.9%52-week weekly-return volatility.
Up/down split23/26Count of positive and negative weeks in the 52-week window.
Average skew13.4% / -13.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis12/100

Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.

Activity pressure 0.01; No reversal markers Factors57/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 37; Small Cap Core rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 40 relevant articles.

EMAT Q1 2026 Earnings: Severe EPS Miss and 17.19% Stock Decline Expose Deep Operational Strain - Earnings Quality Score Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20262.81 USD-23.2%7.43 USD10.02 USD-1.09-74.061.7MOff
31 Jul 20263.66 USD-27.8%7.88 USD10.06 USD-1.07-65.18556.6KOff
24 Jul 20265.07 USD1.6%8.15 USD10.10 USD-0.95-52.37398.2KOff
17 Jul 20264.99 USD-11.4%8.33 USD10.13 USD-0.69-54.50276.5KOff
10 Jul 20265.63 USD-11.1%8.52 USD10.16 USD-0.45-51.59543.4KOff
3 Jul 20266.33 USD-10.3%8.69 USD10.19 USD-0.43-45.62264.9KOff
26 Jun 20267.06 USD-5.1%8.81 USD10.21 USD-0.40-40.11362.1KOff
19 Jun 20267.44 USD9.3%8.92 USD10.23 USD-0.45-40.54311.1KOff
12 Jun 20266.81 USD2.6%9.04 USD10.24 USD-0.46-44.81333.5KOff
5 Jun 20266.64 USD-1.6%9.19 USD10.26 USD-0.17-45.65487.0KOff
29 May 20266.75 USD-15.5%9.39 USD10.28 USD0.12-47.90979.3KOff
22 May 20267.99 USD1.7%9.57 USD10.30 USD0.33-37.31569.6KOff
15 May 20267.86 USD-17.3%9.80 USD10.31 USD0.47-38.35657.9KOff
8 May 20269.50 USD-2.1%9.97 USD10.32 USD0.20-26.53627.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context